25.04.2016 • NewsChinaDede WillamsHMD

Invista Deepens Footprint in China

Mark Evans/Getty Images
Mark Evans/Getty Images

US nylon producer Invista is deepening its footprint in China with the start-up of a new 215,000 t/y plant for hexamethylene diamine (HMD) plant at the Shanghai Chemical Industry Park (SCIP), along with a PTA production line at its joint venture with China Prosperity (Jiangyin) Petrochemical Company, also known as Hanbang Petrochemical.

Invista said the new HMD plant will leverage its most advanced technology to produce the key intermediate for production of PA 6.6 polymer and fiber as well as polyurethanes and high performance nylons.

The unit is part of the company’s new production complex being brought on stream at the Shanghai site, for which groundbreaking ceremonies were held a year ago. Other facilities at the site were planned to include a 150,000 t/y plant for PA 6.6 and a 300,000 t/y plant for adiponitrile (ADN) plant. The total investment of more than $ 1 billion, is said to be the company’s largest ever. China Prosperity’s PTA plant, for which no capacity was disclosed, is the Chinese producer’s second; the first also uses an Invista process.

The new unit will use Invista’s  E2R, Solvent Interchange and R2R technologies, which the nylon specialist said will further enhance its competitiveness in terms of capital productivity, variable cost and environmental performance.

Invista said its Solvent Interchange technology, for which it claims  “inherently low” capital cost, has been successfully deployed with additional advantages achieved through the use of locally manufactured rotary pressure filters. China Prosperity is currently building a polyester resin plant that will use Invista technology.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.